Second, Humedica gets to keep the de-identified but extremely valuable, comprehensive longitudinal patient data, package it, and sell it to interested third parties (e.g. payors and pharmas).
FORBES: We Have A Winner! Quick Take On The Humedica Acquisition By United Health